Why the FDA Is Paying More Attention to 503A & 503B Pharmacies If you've been watching the compounding space, especially around GLP 1s and peptides, you've probably noticed something. The FDA is paying What is a 503B outsourcing facility, and why are so many of them uninspected by FDA? Partnership for Safe Medicines A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read Industry Update: Interim 503A and 503B Bulks Lists New Revisions Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma